Chronic	chronic	O	B_disease
active	active	O	I_disease
hepatitis	hepatitis	O	S_disease
associated	associated	O	O
with	with	O	O
diclofenac	diclofenac	B_chemicals	O
sodium	sodium	S_chemicals	O
therapy	therapy	O	O
.	.	O	O

Diclofenac	diclofenac	B_chemicals	O
sodium	sodium	S_chemicals	O
(	(	O	O
Voltarol	voltarol	O	O
,	,	O	O
Geigy	geigy	O	O
Pharmaceuticals	pharmaceuticals	S_chemicals	O
)	)	O	O
is	is	O	O
a	a	O	O
non-steroidal	non-steroidal	B_chemicals	O
anti-inflammatory	anti-inflammatory	I_chemicals	O
derivative	derivative	O	O
of	of	O	O
phenylacetic	phenylacetic	S_chemicals	O
acid	acid	S_chemicals	O
.	.	O	O

Although	although	O	O
generally	generally	O	O
well-tolerated	well-tolerated	O	O
,	,	O	O
asymptomatic	asymptomatic	O	O
abnormalities	abnormalities	O	O
of	of	O	O
liver	liver	O	O
function	function	O	O
have	have	O	O
been	been	O	O
recorded	recorded	O	O
and	and	O	O
,	,	O	O
less	less	O	O
commonly	commonly	O	O
,	,	O	O
severe	severe	O	O
hepatitis	hepatitis	O	S_disease
induced	induced	O	O
by	by	O	O
diclofenac	diclofenac	S_chemicals	O
.	.	O	O

The	the	O	O
patient	patient	O	O
described	described	O	O
developed	developed	O	O
chronic	chronic	O	B_disease
active	active	O	I_disease
hepatitis	hepatitis	O	S_disease
after	after	O	O
six	six	O	O
months	months	O	O
therapy	therapy	O	O
with	with	O	O
diclofenac	diclofenac	B_chemicals	O
sodium	sodium	S_chemicals	O
which	which	O	O
progressed	progressed	O	O
despite	despite	O	O
the	the	O	O
withdrawal	withdrawal	O	O
of	of	O	O
the	the	O	O
drug	drug	S_chemicals	O
,	,	O	O
a	a	O	O
finding	finding	O	O
not	not	O	O
previously	previously	O	O
reported	reported	O	O
.	.	O	O

